Evidence map›Paper›PMID 11581393›Full record

ArticleJournal of virology2001

Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system.

P Ward, M Falkenberg, P Elias, M Weitzman, R M Linden

Abstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Human bocavirus: lessons learned to date.Pathogens (Basel, Switzerland) · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P WardInstitute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. wardp01@doc.mssm.edu
M Falkenberg
P Elias
M Weitzman
R M Linden

Funding

CIS-REQUIREMENTS FOR RECOMBINANT AAV PRODUCTIONR21DK057746 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI LINDEN, RALPH MICHAEL · 2000 to 2001
$339k
TARGETING OF AAV REP MEDIATED SPECIFIC DNA INTEGRATIONR21DK055609 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI LINDEN, RALPH MICHAEL · 1999 to 2000
$168k
NIDDK NIH HHS DK55609NIDDK NIH HHS DK57746
6 · The paper itself

Abstract

Productive infection by adeno-associated virus type 2 (AAV) requires coinfection with a helper virus, e.g., adenovirus or herpesviruses. In the case of adenovirus coinfection, the replication machinery of the host cell performs AAV DNA replication. In contrast, it has been proposed that the herpesvirus replication machinery might replicate AAV DNA. To investigate this question, we have attempted to reconstitute AAV DNA replication in vitro using purified herpes simplex virus type 1 (HSV-1) replication proteins. We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length. Initiation can occur also on templates containing only a Rep binding site and a terminal resolution site. We further demonstrate that initiation of DNA synthesis can take place with a subset of these factors: Rep68 and the UL29, UL30, and UL42 gene products. Since the HSV polymerase and its accessory factor (the products of the UL30 and UL42 genes) are unable to efficiently perform synthesis by strand displacement, it is likely that in addition to creating a hairpin primer, the AAV Rep protein also acts as a helicase for DNA synthesis. The single-strand DNA binding protein (the UL29 gene product) presumably prevents reannealing of complementary strands. These results suggest that AAV can use the HSV replication apparatus to replicate its DNA. In addition, they may provide a first step for the development of a fully reconstituted AAV replication assay.

Indexed as

DNA-Binding ProteinsDNA ReplicationVirus ReplicationDependovirusDNA HelicasesHeLa CellsHerpesvirus 1, HumanHumansTrans-ActivatorsDNA-Binding ProteinsDNA Helicasesreplication initiator proteinTrans-Activators

Identifiers

PMID11581393
PMCPMC114599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.